In the realm of medical technology and industry strategies for addressing the challenges of an aging society, the concept of “health span” reigns supreme, surpassing mere longevity in significance. This profound notion was at the heart of discussions during the prestigious “World Bio Summit 2025,” a collaborative event orchestrated by the Ministry of Health and Welfare and the esteemed World Health Organization (WHO).
Diving into the second session themed “Aging & Medical Technology” at the Shilla Hotel in Jung-gu, Seoul, a diverse array of experts and industry representatives hailing from Denmark, Singapore, Japan, and South Korea delved deep into the intricacies of medical technology innovation, the emergence of Age-Tech encompassing robotics and artificial intelligence (AI), welfare policies tailored for the elderly, and strategic approaches to invigorating the industry landscape.
Embracing Technological Advancements for Enhanced Elderly Care
Maas Friborg, the Health Counselor at the Embassy of Denmark in Korea, shed light on Denmark’s progressive approach to elderly care reform. Through a tax-based public funding system that upholds the independence and dignity of the elderly, Denmark has witnessed a shift towards home-based care over institutionalization. Noteworthy is Denmark’s embrace of robotics technology as a national strategy to alleviate the burden on caregivers and enhance operational efficiency, all while ensuring data security and standardization remain paramount.
Lee Donghee, Director at the Korea Institute for Industrial Economics & Trade, painted a visionary picture of the societal transformations heralded by technological advancements in the realm of Age-Tech. Looking ahead to 2045, Lee envisioned a future where AI and medical technology could propel humanity beyond biological constraints, emphasizing the need to translate these advancements into tangible market products and services. He aptly highlighted the challenge posed by real estate-centric assets held by South Korea’s baby boomer generation, underscoring the imperative to boost disposable incomes among the elderly to foster the widespread adoption of Age-Tech solutions.
Navigating Industry Fragmentation Towards an Integrated Ecosystem
The CEO of Zenko Motors Academy in Singapore drew attention to the fragmented nature of aging-related technologies prevalent in clinical settings, likening the experience to assembling a PC from disparate components. Proposing the concept of an integrated ‘Rehab Relation 4.0’ ecosystem, he underscored the necessity of collaborative efforts among key stakeholders – patients, caregivers, medical professionals, scientists, industry players, and policymakers – to cultivate sustainable systems. The CEO stressed the pivotal role of data-driven personalized care in mitigating the effects of aging and functional decline, advocating for the realization of AI-driven personalized, predictive, and preventive medicine.
Yoon Hyunju, a Senior Social Development Specialist at the Asian Development Bank (ADB), accentuated the transformative potential of AI in the realm of healthcare through a compelling case study from China. By leveraging AI-powered nurse education and case management tools, the ADB has empowered nurses to enhance their skills and knowledge on-the-go, catering to the unique challenges faced by female nurses juggling caregiving responsibilities. The ADB’s comprehensive elderly care project in China, coupled with urban revitalization efforts and nurse capacity-building initiatives, underscores the pivotal role of accessible and affordable technology in supporting vulnerable demographic groups.
Pioneering Medical Innovation for Enhanced Quality of Life
Choi Jaeyeon, the CEO of Gilead Sciences Korea, articulated a visionary perspective on the trajectory of medical innovation in an era dominated by aging populations. Highlighting the imperative of shifting focus from mere life extension towards curative therapies, preventive measures, and quality of life enhancements, Choi underscored the societal benefits derived from innovative treatments such as Gilead’s hepatitis C therapy boasting high cure rates. By championing AI- and big data-driven personalized treatments in dementia care, Choi envisioned a future where dementia would be relegated to the annals of history, underscoring the urgent need for regulatory agility to keep pace with healthcare innovation.
In conclusion, Lee Yunhwan, the President of the Korean Gerontological Society, encapsulated the essence of the discussion by emphasizing the paramount importance of health span over longevity. He underscored the imperative of a multidisciplinary approach that unites academia, industry, government bodies, and international organizations to surmount obstacles hindering the diffusion and commercialization of technology. With a collaborative spirit and institutional enhancements, the realization of a dignified old age characterized by optimal health span is indeed within reach.
Takeaways:
– Embrace technological advancements to enhance elderly care and promote independent living.
– Foster collaboration among key stakeholders to build integrated ecosystems for sustainable healthcare solutions.
– Champion data-driven personalized care to mitigate the effects of aging and functional decline.
– Shift focus towards curative therapies, preventive measures, and quality of life enhancements in medical innovation.
Tags: sports, regulatory
Read more on asiae.co.kr